摘要
Recently,Lloyd Bod et al.published a study in Nature that identified the B-cell immune checkpoint T cell immunoglobulin and mucin domain 1(TIM-1)and mechanistically elucidated that targeting TIM-1 enhances the responses to type I interferon(IFN-I),promotes B cells antigen presentation and activation,subsequently enhances anti-tumour responses of CD4^(+) and CD8^(+)T cells and inhibits tumour growth.This study provides important implications for anti-tumour therapy.
基金
the Key Research and Development Project of Sichuan Provincial Science and Technology Department(No.23ZDYF2875).
